Skip to content

Clinical trials

Peripheral Arterial Disease trials in the United Kingdom with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Not applicable Country / region: United Kingdom Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20111
20121
20132
20144
20152
20163
20172
20182
20192
20201
20214
20222
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status5
Terminated4
Recruiting2
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Imperial College London4
Glasgow Caledonian University2
Guy's and St Thomas' NHS Foundation Trust2
Hull University Teaching Hospitals NHS Trust2
Mid and South Essex NHS Foundation Trust2
Sheffield Teaching Hospitals NHS Foundation Trust2
Attikon Hospital1
Cook Research Incorporated1
Coventry University1
Imperial College Healthcare NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease32
Intermittent Claudication16
Peripheral Vascular Diseases7
Agnosia2
Chronic Limb-Threatening Ischemia2
Atherosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Diabetic Foot1
Hyperthermia1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.